{"company":{"id":1824782,"name":"Capricor Therapeutics, Inc.","domain":"capricor.com","url":"https://alion.io/company/capricor"},"section":"news","answer":"Capricor Therapeutics, Inc.: 27 headlines on record, 14 headlines in the last 90 days. Its story counts 3 milestones.","figures":[{"label":"Headlines","value":"27"},{"label":"In 90 days","value":"14"},{"label":"Milestones","value":"3"}],"blocks":[{"key":"news","title":"Headlines","source":"the outlets named on each headline, each story once","rows":26},{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":3}],"news":[{"date":"2026-09-30","kind":"News","title":"Capricor Therapeutics (CAPR) Stock Surges on Extended Duchenne Treatment Data","source":"Blockonomi","url":"https://blockonomi.com/capricor-therapeutics-capr-stock-surges-on-extended-duchenne-treatment-data/"},{"date":"2026-09-30","kind":"News","title":"Capricor (CAPR) Stock Jumps as Duchenne Drug Clears Key Data Hurdle","source":"CoinCentral","url":"https://coincentral.com/capricor-capr-stock-jumps-as-duchenne-drug-clears-key-data-hurdle/"},{"date":"2026-09-29","kind":"Press release","title":"Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC) and Capricor Therapeutics (CAPR)","source":"The Globe and Mail","url":"https://theglobeandmail.com/investing/markets/stocks/CAPR/pressreleases/4848443/analysts-offer-insights-on-healthcare-companies-irhythm-technologies-irtc-and-capricor-therapeutics-capr/"},{"date":"2026-09-25","kind":"News","title":"Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026","source":"NewMediaWire","url":"https://newmediawire.com/news/kaplan-fox-urges-capricor-therapeutics-inc-nasdaq-capr-investors-to-contact-the-firm-before-the-deadline-on-september-28-2026-7090081"},{"date":"2026-09-24","kind":"News","title":"Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) - Lead Plaintiff Deadline is September 28, 2026","source":"NewMediaWire","url":"https://newmediawire.com/news/kaplan-fox-announces-a-securities-class-action-filed-against-capricor-therapeutics-inc-nasdaq-capr-lead-plaintiff-deadline-is-september-28-2026-7090038"},{"date":"2026-09-24","kind":"Press release","title":"SueWallSt Reminds Capricor Therapeutics Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 28, 2026 - CAPR","source":"PRNewswire","url":"https://prnewswire.com/news-releases/suewallst-reminds-capricor-therapeutics-investors-of-the-pending-class-action-lawsuit-with-a-lead-plaintiff-deadline-of-september-28-2026---capr-302888725.html"},{"date":"2026-09-23","kind":"News","title":"Capricor Therapeutics (CAPR) Stock Gets Fair Value Boost After Deramiocel Analyst Revisions","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/capricor-therapeutics-capr-stock-gets-131904781.html"},{"date":"2026-09-22","kind":"Press release","title":"CAPR Class Action: Capricor Therapeutics Investors are Notified of the Upcoming September 28 Deadline in Ongoing Securities Fraud Class Action over Clinical Data","source":"PRNewswire","url":"https://prnewswire.com/news-releases/capr-class-action-capricor-therapeutics-investors-are-notified-of-the-upcoming-september-28-deadline-in-ongoing-securities-fraud-class-action-over-clinical-data-302885424.html"},{"date":"2026-09-19","kind":"Press release","title":"Capricor Therapeutics, Inc. Stockholders with Significant Losses Should Contact Robbins LLP Before the Pending September 28, 2026 Lead Plaintiff Deadline","source":"PRNewswire","url":"https://prnewswire.com/news-releases/capricor-therapeutics-inc-stockholders-with-significant-losses-should-contact-robbins-llp-before-the-pending-september-28-2026-lead-plaintiff-deadline-302883636.html"},{"date":"2026-09-17","kind":"News","title":"Capricor Therapeutics to Present HOPE-3 and HOPE-3 Open-Label Extension Data at 2026 World Muscle Society Congress","source":"YahooFinance","url":"https://finance.yahoo.com/healthcare/articles/capricor-therapeutics-present-hope-3-123000831.html"},{"date":"2026-09-03","kind":"News","title":"CAPR Investor Alert: Capricor Therapeutics, Inc. Securities Class Action Notice - Contact SueWallSt - AOL","source":"AOL.com","url":"https://aol.com/articles/capr-investor-alert-capricor-therapeutics-141100000.html"},{"date":"2026-09-01","kind":"Press release","title":"CAPR Class Action Alert: Capricor Therapeutics Clinical Data Issues and Subsequent 64% Stock Drop Lead to Investor Securities Fraud Class Action to Recover Losses","source":"morningstar.com","url":"https://morningstar.com/news/pr-newswire/20260901ny37313/capr-class-action-alert-capricor-therapeutics-clinical-data-issues-and-subsequent-64-stock-drop-lead-to-investor-securities-fraud-class-action-to-recover-losses"},{"date":"2026-08-24","kind":"Press release","title":"Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA","url":"https://capricor.com/investors/news-events/press-releases/detail/354/capricor-therapeutics-announces-extension-of-pdufa-target"},{"date":"2026-08-13","kind":"Press release","title":"Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://capricor.com/investors/news-events/press-releases/detail/353/capricor-therapeutics-reports-second-quarter-2026-financial"},{"date":"2026-08-10","kind":"Press release","title":"Capricor Therapeutics to Report Second Quarter 2026 Financial Results and Provide Recent Corporate Update on August 13","url":"https://capricor.com/investors/news-events/press-releases/detail/352/capricor-therapeutics-to-report-second-quarter-2026"},{"date":"2026-07-30","kind":"Press release","title":"Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel","url":"https://capricor.com/investors/news-events/press-releases/detail/351/capricor-therapeutics-provides-update-on-fda-advisory"},{"date":"2026-07-29","kind":"Press release","title":"The Lancet Publishes HOPE-3 Data for Capricor Therapeutics' Deramiocel in Duchenne Muscular Dystrophy","url":"https://capricor.com/investors/news-events/press-releases/detail/350/the-lancet-publishes-hope-3-data-for-capricor"},{"date":"2026-07-27","kind":"Press release","title":"Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel","url":"https://capricor.com/investors/news-events/press-releases/detail/349/capricor-comments-on-briefing-materials-ahead-of-july-29"},{"date":"2026-06-26","kind":"Press release","title":"Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy","url":"https://capricor.com/investors/news-events/press-releases/detail/348/capricor-therapeutics-announces-fda-advisory-committee"},{"date":"2026-06-26","kind":"Press release","title":"Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference","url":"https://capricor.com/investors/news-events/press-releases/detail/347/capricor-to-present-positive-five-year-hope-2-ole-data-and"},{"date":"2026-06-08","kind":"Press release","title":"Capricor Therapeutics to Present at Upcoming Investor Conferences","url":"https://capricor.com/investors/news-events/press-releases/detail/346/capricor-therapeutics-to-present-at-upcoming-investor"},{"date":"2025-12-16","kind":"News","title":"INVESTOR ALERT: Capricor Therapeutics, Inc. (CAPR) Securities Fraud Class Action Lawsuit Filed; September 28, 2026, Lead Plaintiff Deadline","source":"The Globe and Mail","url":"https://theglobeandmail.com/investing/markets/markets-news/NewMediaWire/3994413/investor-alert-capricor-therapeutics-inc-capr-securities-fraud-class-action-lawsuit-filed-september-28-2026-lead-plaintiff-deadline/"},{"date":"2025-12-10","kind":"News","title":"What Does the Market Think About Capricor Therapeutics Inc?","source":"benzinga.com","url":"https://benzinga.com/insights/short-sellers/25/12/49311683/what-does-the-market-think-about-capricor-therapeutics-inc"},{"date":"2025-06-15","kind":"News","title":"Decoding Capricor Therapeutics's Options Activity: What's the Big Picture?","source":"Nasdaq","url":"https://nasdaq.com/articles/decoding-capricor-therapeuticss-options-activity-whats-big-picture"},{"date":"2024-11-13","kind":"News","title":"Decoding 12 Analyst Evaluations For Capricor Therapeutics","source":"Nasdaq","url":"https://nasdaq.com/articles/decoding-12-analyst-evaluations-capricor-therapeutics"},{"kind":"News","title":"HOPE-3 Phase 3 dataset","source":"thelancet.com","url":"https://thelancet.com/journals/lancet/article/PIIS0140-6736(26)01385-1/fulltext"}],"story":[{"title":"Went public NASDAQ: CAPR"},{"title":"Founded"},{"title":"Won a grant $1.7M · CORDIS","url":"https://www.sbir.gov/awards?keywords=1UT2HL131226-01"}],"as_of":"2026-11-17","cite":"Capricor Therapeutics, Inc., News. Alion, Nov 17, 2026. https://alion.io/company/capricor/news","html_url":"https://alion.io/company/capricor/news","json_url":"https://alion.io/company/capricor/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-17T22:51:02Z"}}